-+ 0.00%
-+ 0.00%
-+ 0.00%

ANGELINI VENTURES AND EIB CO-LEAD $58 MILLION SERIES A FINANCING IN ROUGE THERAPEUTICS TO ADVANCE FIRST-IN-CLASS TREATMENT FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA

Reuters·10/06/2026 07:01:50

Please log in to view news